Literature DB >> 19373618

Reproductive aging, sex steroids, and mood disorders.

Veronica Harsh1, Samantha Meltzer-Brody, David R Rubinow, Peter J Schmidt.   

Abstract

Epidemiologic studies have documented that the majority of women do not become depressed during the menopause transition. However, recent longitudinal studies suggest that in some women, the events related to the menopause transition could play a role in the onset of depression. In this article we review evidence suggesting a relationship between the menopause transition and depression. Additionally, we describe several findings that suggest a role of ovarian hormones in the onset of these depressions, including the clustering of episodes of depression during the stage of the menopause transition that is accompanied by estradiol withdrawal, and the therapeutic effects of short-term estradiol in depressed perimenopausal women. Finally, we discuss possible causes of affective disturbances during the menopause transition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373618      PMCID: PMC2861986          DOI: 10.1080/10673220902891877

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  163 in total

Review 1.  Social environment effects on health and aging: integrating epidemiologic and demographic approaches and perspectives.

Authors:  T E Seeman; E Crimmins
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

2.  The Stages of Reproductive Aging Workshop.

Authors:  Isolde Den Tonkelaar; Frank J Broekmans; Evelien J De Boer; Egbert R Te Velde; Michael R Soules; Estella Parrott; Robert Rebar; Nanette Santoro; Sherry Sherman; Wulf Utian; Nancy F Woods
Journal:  Menopause       Date:  2002 Nov-Dec       Impact factor: 2.953

Review 3.  Hormone replacement therapy for cognitive function in postmenopausal women.

Authors:  E Hogervorst; K Yaffe; M Richards; F Huppert
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 4.  Postmenopausal hormone therapy in clinical perspective.

Authors:  Howard N Hodis; Wendy J Mack
Journal:  Menopause       Date:  2007 Sep-Oct       Impact factor: 2.953

5.  Double-blind treatment of major depression with dehydroepiandrosterone.

Authors:  O M Wolkowitz; V I Reus; A Keebler; N Nelson; M Friedland; L Brizendine; E Roberts
Journal:  Am J Psychiatry       Date:  1999-04       Impact factor: 18.112

6.  Evaluation of four proposed bleeding criteria for the onset of late menopausal transition.

Authors:  Siobán D Harlow; Kevin Cain; Sybil Crawford; Lorraine Dennerstein; Roderick Little; Ellen S Mitchell; Bin Nan; John F Randolph; John Taffe; Matheos Yosef
Journal:  J Clin Endocrinol Metab       Date:  2006-06-13       Impact factor: 5.958

7.  Estrogen increases the density of 5-hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat.

Authors:  B E Summer; G Fink
Journal:  J Steroid Biochem Mol Biol       Date:  1995-07       Impact factor: 4.292

8.  Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.

Authors:  Peter J Schmidt; Robert C Daly; Miki Bloch; Mark J Smith; Merry A Danaceau; Linda Simpson St Clair; Jean H Murphy; Nazli Haq; David R Rubinow
Journal:  Arch Gen Psychiatry       Date:  2005-02

9.  Involutional melancholia revisited.

Authors:  R P Brown; J Sweeney; E Loutsch; J Kocsis; A Frances
Journal:  Am J Psychiatry       Date:  1984-01       Impact factor: 18.112

10.  Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: variations with plasma oestrogen levels and depressive symptoms.

Authors:  P Guicheney; D Léger; J Barrat; R Trévoux; B De Lignières; P Roques; J P Garnier; P Boyer; J Grenier; C Dreux
Journal:  Eur J Clin Invest       Date:  1988-06       Impact factor: 4.686

View more
  13 in total

Review 1.  Enduring influence of pubertal stressors on behavioral response to hormones in female mice.

Authors:  Jeffrey D Blaustein; Nafissa Ismail
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

Review 2.  Menopause in multiple sclerosis: therapeutic considerations.

Authors:  Riley Bove; Tanuja Chitnis; Maria Houtchens
Journal:  J Neurol       Date:  2013-10-08       Impact factor: 4.849

Review 3.  Review: Puberty as a time of remodeling the adult response to ovarian hormones.

Authors:  Jeffrey D Blaustein; Nafissa Ismail; Mary K Holder
Journal:  J Steroid Biochem Mol Biol       Date:  2015-05-21       Impact factor: 4.292

4.  Regulation of the mouse medial prefrontal cortical synapses by endogenous estradiol.

Authors:  Christopher Galvin; Ipe Ninan
Journal:  Neuropsychopharmacology       Date:  2014-03-10       Impact factor: 7.853

5.  The role of family history of depression and the menopausal transition in the development of major depression in midlife women: Study of women's health across the nation mental health study (SWAN MHS).

Authors:  Alicia Colvin; Gale A Richardson; Jill M Cyranowski; Ada Youk; Joyce T Bromberger
Journal:  Depress Anxiety       Date:  2017-05-10       Impact factor: 6.505

Review 6.  Synaptic regulation of affective behaviors; role of BDNF.

Authors:  Ipe Ninan
Journal:  Neuropharmacology       Date:  2013-06-06       Impact factor: 5.250

Review 7.  Accelerated ovarian failure: a novel, chemically induced animal model of menopause.

Authors:  Tracey A Van Kempen; Teresa A Milner; Elizabeth M Waters
Journal:  Brain Res       Date:  2011-01-04       Impact factor: 3.252

Review 8.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

9.  Female reproductive life cycle and hormones: methodology to improve clinical trials.

Authors:  Marlene P Freeman; Rosemary Walker; Thomas P Laughren; Karen K Miller; Maurizio Fava
Journal:  J Clin Psychiatry       Date:  2013-10       Impact factor: 4.384

10.  Effects of social housing on hippocampal dendrites and behavior in ovariectomized rats.

Authors:  Gail M Leedy; Lorraine F Barrows; Suzanne Clark
Journal:  Brain Res Bull       Date:  2012-11-26       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.